Xinhua Silk Road - Belt and Road Portal, China's silk road economic belt and 21st Century Maritime Silk Road Website Xinhua Silk Road - Belt and Road Portal, China's silk road economic belt and 21st Century Maritime Silk Road Website
Subscribe CustomBlackClose

Belt & Road Weekly Subscription Form

download_pop

Research ReportCustomBlackClose

The full edition of the report is available at Xinhua Silk Road Database. You can click the “Table of Content” to have a general understanding of it.

Click on the button below to create your account and get immediate access to thousands of articles.

Start a Free Trial

Xinhua Silk Road Database
equity investment Sorting by the latest release time

  • Huadong Medicine completes equity investment in Heidelberg Pharma

    Chinese pharmaceutical firm Huadong Medicine Co., Ltd. (Huadong Medicine, 000963.SZ) announced on Wednesday that its wholly-owned subsidiary Huadong Medicine Investment Holding (Hong Kong) Limited has finished the equity investment in Heidelberg Pharma in Germany on Tuesday and become the second largest shareholder of the company with 35 percent of its equity.

    September08,2022


  • 【Financial Str. Release】China supports mid-, long-term funds to shore up equity investment, official

    China Securities Regulatory Commission (CSRC), the sector regulator, will coordinate with other related sides to resolve the policy obstacles to support mid- and long-term funds to raise their proportion of equity investment, Wang Jianjun, deputy head with the CSRC told Xinhua in an interview recently.

    May11,2022


  • China's equity investment market brisk in first three quarters: report

    Equity investment in China has been brisk this year as the volume of funds raised and investment witnessed substantial growth in the first three quarters, an industrial report showed.

    November29,2021


  • China SOEs see more equity investment from social capital in 2020

    China's state-owned enterprises (SOEs) saw more social capital investments in 2020 as the country steps up mixed-ownership reform to improve SOE efficiency.

    June01,2021


  • Insurers expected to add RMB300 bln equity investment in 2021, institution

    Insurers in China are likely to upsize their equity investment by around 300 billion yuan alongside increases in premium incomes in the coming year, reported Xinhua Finance, a Xinhua-run financial information platform on Thursday.

    December25,2020


  • China's national financing guarantee fund signs contracts for first batch of equity inv.

    China's National Financing Guarantee Fund signed contracts for its first batch of equity investment deals with a dozen of government-backed financing guarantee institutions on November 20, reported Xinhua Finance, a financial information platform run by Xinhua News Agency.

    November23,2020


  • Many industries expected to benefit from looser equity inv. requirements for insurers, expert

    China's traditional industries, emerging sectors, high-tech industries, advanced manufacturing and new consumption sectors are likely to lure more insurance capital to come in, reported Xinhua Finance Wednesday.

    November18,2020


  • CBIRC allows qualified insurers to properly raise equity investment proportion

    Chinese insurers with high solvency ratio and good asset quality are allowed to properly raise their equity investment proportion from the current ceiling of 30 percent, reported Xinhua Finance, a financial information platform run by Xinhua News Agency Monday.

    March23,2020


  • Ask Us A Question belt & road login close

    If you have any questions, please enter them in the box below.

    Identifying code Reload

    Write to Us belt & road login close

    Do you want to be a contributor to Xinhua Silk Road and tell us your Belt & Road story? Send your articles to silkroadweekly@xinhua.org and share your stories with more people.

    Click on the button below to create your account and get im http://img.silkroad.news.cn/templates/silkroad/en2017te access to thousands of articles.

    Start a Free Trial